Company profile

Trimerbody Pharma

Molecular Engineering for Health

Industry
Research
Employees
6
Headquarters
Tres Cantos, Comunidad de Madrid
LinkedIn followers
1,495
Office locations
2

Trimerbody Pharma company summary

Trimerbody Pharma is a company in the Research industry, headquartered in Tres Cantos, Comunidad de Madrid. On LinkedIn the company has around 6 employees and 1,495 followers. The company lists 2 office locations. Its listed specialties include Biotechnology, Recombinant Antibodies, Protein Engineering, Multivalent Antibodies, Bispecific Antibodies.

What technology does Trimerbody Pharma use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Trimerbody Pharma

Trimerbody Pharma is a company developing bispecific tumor targeted antibodies based on its highly innovative protein engineering platform Trimerbody®. Trimerbodies provide several advantages over conventional monoclonal antibodies, such as simultaneous multiple targeting (up to six different targets per molecule), reduced size, higher avidity for targets, and a variety of effector possibilities (immune system activation, receptor blocking, delivery of toxins or cytokines). 

 Trimerbody is a novel class of proprietary multivalent and multispecific therapeutic proteins based on specific antigen-binding domains and the unique structural and functional properties of naturally occurring collagen trimerization domains. LeadArtis’s proprietary platform allows rapid generation and production of novel biological therapeutics with potential in a wide range of human diseases. The technology was originally developed following the discovery that fully functional multivalent and multispecific antibodies could be generated by employing certain engineered collagen trimerization domains and target antigen binding domains consisting of conventional single-chain antibody fragments (scFv), single-domain antibodies or antibody mimetics. As a result, the recombinant Trimerbodies display enhanced antigen-binding capacity and are very stable. Trimerbodies, with their unique structural and functional properties, form the basis of a new generation of therapeutic molecules, which due to their small size and unique structure are ideal for the generation of novel biological drugs with multiple competitive advantages over other therapeutic molecules. LeadArtis development portfolio focusses on therapeutic areas such as immuno-oncology and inflammatory-autoimmune diseases. LeadArtis offers also licensing opportunities, offering its Trimerbody® technology to biopharmaceutical companies.

Specialties

BiotechnologyRecombinant AntibodiesProtein EngineeringMultivalent AntibodiesBispecific Antibodies

Where is Trimerbody Pharma located?

Trimerbody Pharma lists 2 office locations.

Tres Cantos, Comunidad de Madrid, ESHQ
Calle de Santiago Grisolia
Tres Cantos, Comunidad de Madrid, ES
Calle de Santiago Grisolia

Compare companies similar to Trimerbody Pharma

More companies in Research.

CompanyIndustryEmployeesFoundedHeadquarters
Trimerbody Pharma
trimerbodypharma.com
Research6-Tres Cantos, Comunidad de Madrid
Research4,8231945Pretoria, Gauteng
Research3,088-Mountain View, CA
CSIC
csic.es
Research5,7951939Madrid, Comunidad de Madrid
icddr,b
icddrb.org
Research3,1801960Dhaka , Dhaka
Research7602003Cambridge, MA
Research2371986New Delhi, Delhi
Research181-Wageningen, Gelderland
Research1712017Bengaluru, Karnataka
CIAT
alliancebioversityciat.org
Research1,3431967Cali, Valle del Cauca
Stockholm Resilience Centre
stockholmresilience.org
Research1912007Stockholm, Stockholm

Frequently asked questions about Trimerbody Pharma

What does Trimerbody Pharma do?

Trimerbody Pharma is a company developing bispecific tumor targeted antibodies based on its highly innovative protein engineering platform Trimerbody®. Trimerbodies provide several advantages over conventional monoclonal antibodies, such as simultaneous multiple targeting (up to six different targets per molecule), reduced size, higher avidity for targets, and a variety of effector possibilities (immune system activation, receptor blocking, delivery of toxins or cytokines). 

 Trimerbody is a novel class of proprietary multivalent and multispecific therapeutic proteins based on specific antigen-binding domains and the unique structural and functional properties of naturally occurring collagen trimerization domains. LeadArtis’s proprietary platform allows rapid generation and production of novel biological therapeutics with potential in a wide range of human diseases. The technology was originally developed following the discovery that fully functional multivalent and multispecific antibodies could be generated by employing certain engineered collagen trimerization domains and target antigen binding domains consisting of conventional single-chain antibody fragments (scFv), single-domain antibodies or antibody mimetics. As a result, the recombinant Trimerbodies display enhanced antigen-binding capacity and are very stable. Trimerbodies, with their unique structural and functional properties, form the basis of a new generation of therapeutic molecules, which due to their small size and unique structure are ideal for the generation of novel biological drugs with multiple competitive advantages over other therapeutic molecules. LeadArtis development portfolio focusses on therapeutic areas such as immuno-oncology and inflammatory-autoimmune diseases. LeadArtis offers also licensing opportunities, offering its Trimerbody® technology to biopharmaceutical companies.

How many employees does Trimerbody Pharma have?

Trimerbody Pharma has around 6 employees on LinkedIn.

Where is Trimerbody Pharma headquartered?

Trimerbody Pharma is headquartered in Tres Cantos, Comunidad de Madrid.

Where does Trimerbody Pharma have offices?

Trimerbody Pharma lists 2 office locations, including Tres Cantos, Comunidad de Madrid, ES.

Build a lead list from companies like Trimerbody Pharma

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.